Northern Trust Corp Uni Qure N.V. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Uni Qure N.V. stock. As of the latest transaction made, Northern Trust Corp holds 93,928 shares of QURE stock, worth $603,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,928

Previous 84,904 10.63%

Holding current value

$603,017

Previous $441,000 4.76%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $39,615 - $49,000	9,024 Added 10.63%	93,928 $420,000
Q1 2024 May 14, 2024	SELL	$4.82 - $6.93 $10,753 - $15,460	-2,231 Reduced 2.56%	84,904 $441,000
Q4 2023 Feb 13, 2024	SELL	$5.63 - $8.27 $196,931 - $289,276	-34,979 Reduced 28.64%	87,135 $589,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $11.83 $266,541 - $469,923	-39,723 Reduced 24.55%	122,114 $819,000
Q2 2023 Aug 11, 2023	SELL	$11.12 - $22.2 $42,222 - $84,293	-3,797 Reduced 2.29%	161,837 $1.85 Million
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $46,899 - $57,859	2,508 Added 1.54%	165,634 $3.34 Million
Q4 2022 Feb 13, 2023	BUY	$18.12 - $27.32 $74,980 - $113,050	4,138 Added 2.6%	163,126 $3.7 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $335,456 - $504,568	19,756 Added 14.19%	158,988 $2.98 Million
Q2 2022 Aug 12, 2022	BUY	$13.15 - $20.45 $162,310 - $252,414	12,343 Added 9.73%	139,232 $2.6 Million
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $77,207 - $114,165	-5,310 Reduced 4.02%	126,889 $2.29 Million
Q4 2021 Feb 08, 2022	BUY	$20.24 - $36.01 $1,882 - $3,348	93 Added 0.07%	132,199 $2.74 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $998,393 - $1.47 Million	38,385 Added 40.96%	132,106 $4.23 Million
Q2 2021 Aug 13, 2021	BUY	$29.97 - $37.17 $110,199 - $136,674	3,677 Added 4.08%	93,721 $2.89 Million
Q1 2021 May 12, 2021	BUY	$29.24 - $42.03 $305,148 - $438,625	10,436 Added 13.11%	90,044 $3.03 Million
Q4 2020 Feb 11, 2021	SELL	$35.35 - $50.67 $85,158 - $122,064	-2,409 Reduced 2.94%	79,608 $2.88 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $2.5 Million - $3.31 Million	69,500 Added 555.24%	82,017 $3.02 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $1.66 Million - $2.5 Million	-36,858 Reduced 74.65%	12,517 $564,000
Q1 2020 May 14, 2020	BUY	$40.01 - $73.97 $68,697 - $127,006	1,717 Added 3.6%	49,375 $2.34 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $101,513 - $204,011	2,734 Added 6.09%	47,658 $3.42 Million
Q3 2019 Nov 13, 2019	BUY	$39.36 - $76.8 $49,514 - $96,614	1,258 Added 2.88%	44,924 $1.77 Million
Q2 2019 Aug 13, 2019	BUY	$52.76 - $82.19 $154,639 - $240,898	2,931 Added 7.2%	43,666 $3.41 Million
Q1 2019 May 13, 2019	BUY	$27.39 - $68.41 $209,506 - $523,268	7,649 Added 23.12%	40,735 $2.43 Million
Q4 2018 Feb 12, 2019	BUY	$22.8 - $33.93 $18,171 - $27,042	797 Added 2.47%	33,086 $954,000
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $486,977 - $705,176	16,369 Added 102.82%	32,289 $1.18 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $349,603 - $635,844	15,920 New	15,920 $602,000

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Uni Qure N.V. Transaction History